Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Syri Limited t/a Thame Laboratories, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, UK
Clonazepam Thame 0.5mg/5ml Oral Solution.
| Pharmaceutical Form |
|---|
|
Oral Solution. Clear, colourless to pale yellow colour solution. |
Each 5ml solution contains 0.5mg Clonazepam.
Excipients with known effect: Each 5ml solution contains 64.68mg of ethanol (96%).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Clonazepam |
Clonazepam exhibits pharmacological properties which are common to benzodiazepines and include anticonvulsive, sedative, muscle relaxing and anxiolytic effects. Animal data and electroencephalographic investigations in man have shown that clonazepam rapidly suppresses many types of paroxysmal activity including the spike and wave discharge in absence seizures (petit mal), slow spike wave, generalised spike wave, spikes with temporal or other locations as well as irregular spikes and waves. |
| List of Excipients |
|---|
|
Ethanol (96%) |
Bottle: Ph. Eur. Type III Amber glass bottle.
Closure: a tamper-evident, child-resistant plastic cap with polypropylene inner, polyethylene outer and expanded polyethylene (EPE) liner.
Dosing Device: a 10ml oral syringe with 0.25ml graduation mark and a syringe adaptor.
Pack size: 150ml.
Syri Limited t/a Thame Laboratories, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, UK
PL 39307/0052
03/08/2017
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
